Join Certara at the Annual J.P. Morgan Healthcare Conference
Certara, Inc. (NASDAQ: CERT), a pioneer in model-informed drug development, is set to make waves at the 43rd Annual J.P. Morgan Healthcare Conference. This prestigious event gathers industry leaders and innovators to discuss advances and opportunities within the healthcare sector.
Event Details
Management from Certara will take center stage for a presentation scheduled for 5:15 PM PT. The engagement will offer insights into the company’s latest developments and strategic vision. This is an excellent opportunity for investors and stakeholders to understand the company's direction and innovations.
Webcast Availability
For those who cannot attend in person, Certara will provide a live webcast of the presentation on their investor relations website. Moreover, the replay will remain accessible for at least 30 days, ensuring that everyone has the chance to catch up on the conversations and insights shared during the conference.
About Certara
Certara is dedicated to accelerating medicine development through cutting-edge biosimulation software, technology, and services. Currently, the company collaborates with over 2,400 clients, ranging from biopharmaceutical firms to academic institutions and regulatory bodies in 66 different countries. This expansive network underscores Certara’s pivotal role in transforming how drugs are discovered and developed.
Connect with Certara
In case of inquiries or further information, Certara encourages outreach through their Investor Relations contact, David Deuchler at Gilmartin Group. Additionally, press inquiries can be made through Alyssa Horowitz. Both contacts represent a direct line to learn more about the company's strategic plans and opportunities.
Importance of Industry Conferences
Industry conferences like the J.P. Morgan Healthcare Conference provide essential platforms for networking, collaboration, and sharing critical information that drives healthcare advancements. Attending these events allows companies like Certara to showcase their contributions and connect with investors, partners, and innovators in the field.
Looking Ahead
As Certara positions itself for success at this important event, stakeholders can expect to hear about exciting developments in the company’s approach to drug development and their continuous efforts to enhance patient therapies through science and innovation. The impressions from such conferences often shape market perceptions and strategic funding opportunities.
Frequently Asked Questions
What is the 43rd Annual J.P. Morgan Healthcare Conference?
It is a prominent event where healthcare leaders gather to share insights and developments in the industry.
When will Certara present at the conference?
Certara will present at 5:15 PM PT.
Is there a way to watch Certara's presentation?
Yes, a live webcast will be available on Certara's investor relations website.
Who can I contact for investor relations at Certara?
David Deuchler is the contact for investor relations at Certara.
What services does Certara provide?
Certara accelerates medicine development through biosimulation software and services for the biopharmaceutical industry.
